• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on August 20, 2016September 14, 2023

Stillbirth

One of the most common adverse pregnancy outcomes is the death of the fetus. Fetal death has a great number of different and legal...
Read More
Posted on August 13, 2016September 14, 2023

Single organ cutaneous vasculitis (SOCV)

AHEI acute hemorrhagic edema of infancy ANCA anti-neutrophil cytoplasmic antibodies BCGB acillus Calmette-Guerin CHCC Chapel Hill...
Read More
Posted on July 10, 2016September 14, 2023

Maternal death

Need for developing case definitions and guidelines for data collection, analysis, and presentation for maternal death as an adver...
Read More
Posted on June 10, 2016September 14, 2023

Congenital anomalies

Congenital anomalies, also commonly referred to as birth defects, congenital disorders, congenital malformations, or congenital ab...
Read More
Posted on April 16, 2016September 14, 2023

Neonatal death

More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunizati...
Read More
Posted on April 13, 2016September 14, 2023

Postpartum haemorrhage

Need for developing case definitions and guidelines for data collection, analysis, and presentation for primary postpartum haemorr...
Read More
Posted on April 13, 2016September 14, 2023

Neonatal infections

Maternal vaccination is an important area of research and requires appropriate and internationally comparable definitions and safe...
Read More
Posted on March 13, 2016September 14, 2023

Pathways to preterm birth

Need for developing case definitions and guidelines for data collection, analysis, and presentation for pathways to preterm birth...
Read More
Posted on March 13, 2016September 14, 2023

Systemic Lupus Erythematosus

Need for developing case definitions and guidelines for data collection, analysis, and presentation for systemic lupus erythematos...
Read More
Posted on February 13, 2016September 14, 2023

Hypertensive disorders of pregnancy

Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders...
Read More
Previous page 1 … 3 4 5 6 7 8 Next page

Recent Posts

  • Safety by Numbers – February 2025February 19, 2025
  • Brighton Collaboration News — Sept 2024September 9, 2024
  • Lessons Learned from Vaccine Safety Surveillance EffortsSeptember 3, 2024
  • Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessmentAugust 27, 2024
  • Safety by Numbers – August 2024August 14, 2024

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy